Titre : | Overdose prevention sites and heroin assisted treatment [Editorial] (2019) |
Auteurs : | S. SHERMAN |
Type de document : | Article : Périodique |
Dans : | British Medical Journal (Vol.366, n°8214, 21 September 2019) |
Article en page(s) : | l5437 |
Langues: | Anglais |
Discipline : | PRE (Prévention - RdRD / Prevention - Harm reduction) |
Mots-clés : |
Thésaurus géographique INTERNATIONALThésaurus mots-clés OPIOIDES ; HEROINE ; SURDOSE ; PREVENTION ; REDUCTION DES RISQUES ET DES DOMMAGES |
Résumé : |
Both improve outcomes for drug users and should be deployed wherever needed.
The current global opioid epidemic is unprecedented, causing big increases in deaths from overdose. In 2018 overdose deaths in England and Wales were at a record high of 4359, representing a 16% increase since 2017. In the US, fatal overdoses fuelled an increase in overall mortality in 2015, the first in over 15 years. Harm reduction interventions - such as distributing sterile syringes (syringe service programmes) and providing medical assisted treatment (such as methadone, buprenorphine) - are cost effective in reducing HIV, hepatitis C, and overdose as well as yielding additional social benefits, including more stable housing among dependent people and lower crime and incarceration rates. Yet the political will, law enforcement support, and wider social tolerance for such interventions have been limited. [Extract] |
Domaine : | Autres substances / Other substances ; Drogues illicites / Illicit drugs |
Sous-type de document : | Editorial |
Refs biblio. : | 15 |
Affiliation : | Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA |
Accueil